连续性肾脏替代治疗的充分性评估

刘晨曦 赵隽永 樊心妍 唐迅子 袁 芳 刘 虹

中国血液净化 ›› 2026, Vol. 25 ›› Issue (04) : 325-329.

中国血液净化 ›› 2026, Vol. 25 ›› Issue (04) : 325-329. DOI: 10.3969/j.issn.1671-4091.2026.04.010
综述

连续性肾脏替代治疗的充分性评估

  • 刘晨曦    赵隽永    樊心妍    唐迅子    袁 芳    刘 虹
作者信息 +

Adequacy assessment of continuous renal replacement therapy

  • LIU Chen-xi, ZHAO Juan-yong, FAN Xin-yan, TANG Xun-zi, YUAN Fang, LIU Hong
Author information +
文章历史 +

摘要

连续性肾脏替代治疗(continuous renal replacement therapy,CRRT)指所有持续、缓慢清除水分和溶质的体外血液净化治疗的总称,是重症患者重要的生命支持技术。随着技术发展和临床经验积累,CRRT的“充分性”评估已从传统的溶质清除剂量扩展至治疗时机、容量管理、抗凝策略、回路监测等多个维度。本文基于最新循证医学证据,系统阐述CRRT充分性评估的关键要素,包括启动时机选择、CRRT剂量与溶质清除监测、容量管理策略、抗凝治疗方案、特殊人群管理以及质量控制体系,以指导临床实践并改善患者预后。

Abstract

Continuous renal replacement therapy (CRRT) is a extracorporeal blood purification method to continuously and slowly clear water and solute from blood, and has become a critical life-support technology for critically ill patients. With the advances of technology and the accumulation of clinical experience, the assessment of CRRT "adequacy" has expanded beyond traditional issue of solute clearance dosage to include multiple dimensions such as treatment timing, fluid management, anticoagulation strategies, and circuit monitoring. Based on the latest evidence-based medical research, this article reviews key elements of CRRT adequacy assessment, including selection of initial time, CRRT dosage, surveillance of solute clearance, volume management strategies, anticoagulation protocols, management of specific patients, and quality control system, in order to optimize CRRT practice and improve patient outcomes.

关键词

连续性肾脏替代治疗 / 充分性 / 个体化治疗

Key words

Continuous renal replacement therapy / Adequacy / Individualized treatment

引用本文

导出引用
刘晨曦 赵隽永 樊心妍 唐迅子 袁 芳 刘 虹. 连续性肾脏替代治疗的充分性评估[J]. 中国血液净化. 2026, 25(04): 325-329 https://doi.org/10.3969/j.issn.1671-4091.2026.04.010
LIU Chen-xi, ZHAO Juan-yong, FAN Xin-yan, TANG Xun-zi, YUAN Fang, LIU Hong. Adequacy assessment of continuous renal replacement therapy[J]. Chinese Journal of Blood Purification. 2026, 25(04): 325-329 https://doi.org/10.3969/j.issn.1671-4091.2026.04.010
中图分类号: R459.5   

参考文献

[1]Hoste E A J, Bagshaw S M, Bellomo R, et al.Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study[J].Intensive care medicine, 2015, 41(8):1411-1423 [2]Yang L, Xing G, Wang L, et al.Acute kidney injury in China: a cross-sectional survey[J].The Lancet, 2015, 386(10002):1465-1471 [3]国家慢性肾病临床医学研究中心, 中国医师协会肾脏内科医师分会, 中国急性肾损伤临床实践指南专家组.中国急性肾损伤临床实践指南[J].中华医学杂志, 2023, 103(42):3332-3366 [4]Teixeira J P, Neyra J A, Tolwani A.Continuous KRT: a contemporary review[J].Clinical Journal of the American Society of Nephrology, 2023, 18(2):256-269 [5]中国医师协会肾脏病医师分会血液透析充分性协作组.中国血液透析充分性临床实践指南[J].中华医学杂志, 2015, 95(34):2748-2753 [6]Clark W R, Leblanc M, Ricci Z, et al.Adequacy of Continuous Renal Replacement Therapy: Prescription and Delivery[J].Critical Care Nephrology, 2019, :1029-1034 [7]Kdigo A K I.Kidney Disease Improving Global Outcomes. AKI Work Group: Clinical practice guideline for acute kidney injury[J].Kidney Int., Suppl, 2012, 2:1-138 [8]Zarbock A, Kellum J A, Schmidt C, et al.Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial[J].JAMA, 2016, 315(20):2190-2199 [9]Gaudry S, Hajage D, Schortgen F, et al.Initiation strategies for renal-replacement therapy in the intensive care unit[J].New England Journal of Medicine, 2016, 375(2):122-133 [10]STARRT-AKI Investigators, Canadian Critical Care Trials Group, Australian and New Zealand Intensive Care Society Clinical Trials Group, et al.Timing of initiation of renal-replacement therapy in acute kidney injury[J].The New England Journal of Medicine, 2020, 383(3):240-251 [11]Barbar S D, Clere-Jehl R, Bourredjem A, et al.Timing of renal-replacement therapy in patients with acute kidney injury and sepsis[J].New England Journal of Medicine, 2018, 379(15):1431-1442 [12]Jeong R, Bagshaw S M, Ghamarian E, et al.Time to Renal Replacement Therapy Initiation in Critically Ill Patients With Acute Kidney Injury: A Secondary Analysis of the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial[J].Critical Care Medicine, 2025, 53(4):e897-e907 [13]Gaudry S, Hajage D, Martin-Lefevre L, et al.Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre,open-label,randomised,controlled trial[J].The Lancet, 2021, 397(10281):1293-1300 [14]VANIH Acute Renal Failure Trial Network.Intensity of renal support in critically ill patients with acute kidney injury[J].New England Journal of Medicine, 2008, 359(1):7-20 [15]RENAL Replacement Therapy Study Investigators.Intensity of continuous renal-replacement therapy in critically ill patients[J].New England Journal of Medicine, 2009, 361(17):1627-1638 [16]Uchino S, Toki N, Takeda K, et al.Validity of low-intensity continuous renal replacement therapy[J].Critical care medicine, 2013, 41(11):2584-2591 [17]Okamoto K, Fukushima H, Kawaguchi M, et al.Low-dose continuous kidney replacement therapy and mortality in critically ill patients with acute kidney injury: a retrospective cohort study[J].American Journal of Kidney Diseases, 2024, 84(2):145-153 [18]Bagshaw S M, Chakravarthi M R, Ricci Z, et al.Precision continuous renal replacement therapy and solute control[J].Blood purification, 2016, 42(3):238-247 [19]Claure-Del Granado R, Macedo E, Chertow G M, et al.Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis[J].Clinical Journal of the American Society of Nephrology, 2011, 6(3):467-475 [20]Lyndon W D, Wille K M, Tolwani A J.Solute clearance in CRRT: prescribed dose versus actual delivered dose[J].Nephrology Dialysis Transplantation, 2012, 27(3):952-956 [21]Garzotto F, Ostermann M, Martín-Langerwerf D, et al.The dose response multicentre investigation on fluid assessment (DoReMIFA) in critically ill patients[J].Critical care, 2016, 20(1):196- [22]Bouchard J, Soroko S B, Chertow G M, et al.Fluid accumulation,survival and recovery of kidney function in critically ill patients with acute kidney injury[J].Kidney international, 2009, 76(4):422-427 [23]中华医学会肾脏病学分会专家组.连续性肾替代治疗容量评估与管理专家共识[J].中华肾脏病杂志, 2024, 40(1):74-81 [24]Murugan R, Bellomo R, Palevsky P M, et al.Ultrafiltration in critically ill patients treated with kidney replacement therapy[J].Nature Reviews Nephrology, 2021, 17(4):262-276 [25]Rewa O G, Tolwani A, Mottes T, et al.Quality of care and safety measures of acute renal replacement therapy: workgroup statements from the 22nd acute disease quality initiative (ADQI) consensus conference[J].Journal of Critical Care, 2019, 54:52-57 [26]Bitker L, Dupuis C, Pradat P, et al.Fluid balance neutralization secured by hemodynamic monitoring versus protocolized standard of care in patients with acute circulatory failure requiring continuous renal replacement therapy: results of the GO NEUTRAL randomized controlled trial[J].Intensive Care Medicine, 2024, 50(12):2061-2072 [27]Murugan R, Ostermann M, Peng Z, et al.Net ultrafiltration prescription and practice among critically ill patients receiving renal replacement therapy: a multinational survey of critical care practitioners[J].Critical care medicine, 2020, 48(2):e87-e97 [28]Teixeira J P, Hiremath S, Kabli A O, et al.Continuous Kidney Replacement Therapies: Core Curriculum 2025[J].American Journal of Kidney Diseases, 2025, 85(6):767-786 [29]Zarbock A, Küllmar M, Kindgen-Milles D, et al.Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: a randomized clinical trial[J].JAMA, 2020, 324(16):1629-1639 [30]Boldt D, Busse L, Chawla L S, et al.Anticoagulation practices for continuous renal replacement therapy: a survey of physicians from the United States[J].Renal Failure, 2023, 45(2):2290932- [31]Hu C, Shui P, Zhang B, et al.How to safeguard the continuous renal replacement therapy circuit: a narrative review[J].Frontiers in Medicine, 2024, 11:1442065- [32]Zarbock A, Nadim M K, Pickkers P, et al.Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup[J].Nature Reviews Nephrology, 2023, 19(6):401-417 [33]Zhang L, Cove M, Nguyen B G, et al.Adsorptive hemofiltration for sepsis management: expert recommendations based on the Asia Pacific experience[J].Chinese Medical Journal, 2021, 134(18):2258-2260 [34]Wang G, He Y, Guo Q, et al.Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: a systematic review and meta-analysis[J].Critical Care, 2023, 27(1):275- [35]丁小强, 许佳瑞, 沈波.重视医疗质量评价和控制 实施高质量[J].中华医学杂志, 2024, 104(44):4017-4021

基金

国家自然科学基金(82470741);2023年湖南省卫生健康高层次人才:领军人才

Accesses

Citation

Detail

段落导航
相关文章

/